BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31875785)

  • 1. Combined surgical and medical treatment in an adolescent with severe gynecomastia due to excessive estradiol secretion: a case report.
    Moon JE; Ko CW; Yang JD; Lee JS
    BMC Pediatr; 2019 Dec; 19(1):515. PubMed ID: 31875785
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and pharmacodynamics of anastrozole in pubertal boys with recent-onset gynecomastia.
    Mauras N; Bishop K; Merinbaum D; Emeribe U; Agbo F; Lowe E
    J Clin Endocrinol Metab; 2009 Aug; 94(8):2975-8. PubMed ID: 19470631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prepubertal gynaecomastia in a boy with Peutz-Jeghers syndrome: managing the aromatase overexpression.
    Simões-Pereira J; Santos F; Lopes L; Limbert C
    J Pediatr Endocrinol Metab; 2018 Oct; 31(10):1149-1154. PubMed ID: 30052520
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dominant transmission of prepubertal gynecomastia due to serum estrone excess: hormonal, biochemical, and genetic analysis in a large kindred.
    Binder G; Iliev DI; Dufke A; Wabitsch M; Schweizer R; Ranke MB; Schmidt M
    J Clin Endocrinol Metab; 2005 Jan; 90(1):484-92. PubMed ID: 15483104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and efficacy of anastrozole for the treatment of pubertal gynecomastia: a randomized, double-blind, placebo-controlled trial.
    Plourde PV; Reiter EO; Jou HC; Desrochers PE; Rubin SD; Bercu BB; Diamond FB; Backeljauw PF
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4428-33. PubMed ID: 15356042
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of pubertal gynecomastia with the specific aromatase inhibitor anastrozole.
    Riepe FG; Baus I; Wiest S; Krone N; Sippell WG; Partsch CJ
    Horm Res; 2004; 62(3):113-8. PubMed ID: 15273427
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prepubertal gynecomastia in Peutz-Jeghers syndrome: incomplete penetrance in a familial case and management with an aromatase inhibitor.
    Lefevre H; Bouvattier C; Lahlou N; Adamsbaum C; Bougnères P; Carel JC
    Eur J Endocrinol; 2006 Feb; 154(2):221-7. PubMed ID: 16452534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. EAA clinical practice guidelines-gynecomastia evaluation and management.
    Kanakis GA; Nordkap L; Bang AK; Calogero AE; Bártfai G; Corona G; Forti G; Toppari J; Goulis DG; Jørgensen N
    Andrology; 2019 Nov; 7(6):778-793. PubMed ID: 31099174
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term Effect of Aromatase Inhibition in Aromatase Excess Syndrome.
    Binder G; Nakamura A; Schweizer R; Ogata T; Fukami M; Nagasaki K
    J Clin Endocrinol Metab; 2021 Apr; 106(5):1491-1500. PubMed ID: 33513243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Management of prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: from aromatase inhibitors to subcutaneous mastectomy.
    Ferraro GA; Romano T; De Francesco F; Grandone A; D'Andrea F; del Giudice EM; Cataldo C; Gatta G; Di Grezia G; Perrone L; Nicoletti G
    Aesthetic Plast Surg; 2013 Oct; 37(5):1012-22. PubMed ID: 23860822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploratory study of drug plasma levels during bicalutamide 150 mg therapy co-administered with tamoxifen or anastrozole for prophylaxis of gynecomastia and breast pain in men with prostate cancer.
    Boccardo F; Rubagotti A; Conti G; Potenzoni D; Manganelli A; Del Monaco D
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):415-20. PubMed ID: 15838655
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anastrozole as a therapeutic option for gynecomastia in a person receiving antiretroviral therapy: Case report.
    Senkoro E; Varadarajan M; Candela C; Gebreselassie A; Antoniadi C; Boffito M
    Br J Clin Pharmacol; 2024 Jan; 90(1):350-353. PubMed ID: 37917870
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prepubertal gynecomastia in two monozygotic twins with Peutz-Jeghers syndrome: two years' treatment with anastrozole and genetic study.
    Grandone A; del Giudice EM; Cirillo G; Santarpia M; Coppola F; Perrone L
    Horm Res Paediatr; 2011; 75(5):374-9. PubMed ID: 21335955
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gynecomastia.
    Ayyavoo A
    Indian J Pediatr; 2023 Oct; 90(10):1013-1017. PubMed ID: 37592101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynaecomastia: the anastrozole paradox.
    Bedognetti D; Rubagotti A; Zoppoli G; Boccardo F
    J Pediatr Endocrinol Metab; 2010; 23(1-2):205-6. PubMed ID: 20432826
    [No Abstract]   [Full Text] [Related]  

  • 16. [Surgical treatment of gynecomastia].
    Târcoveanu E; Lupaşcu C; Vasilescu A; Moldovanu R; Ichim M; Georgescu S; Niculescu D; Dănilă N; Dimofte G; Anton R; Crumpei F; Florea N; Ungureanu C
    Chirurgia (Bucur); 2008; 103(6):643-50. PubMed ID: 19274908
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Severe Gynecomastia: New Technique Using Superior Pedicle NAC Flap Through a Circumareolar Approach.
    Ibrahiem SM
    Ann Plast Surg; 2016 Jun; 76(6):645-51. PubMed ID: 25003440
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of aromatase inhibitor therapy in a case with large cell calcifying Sertoli cell tumour-associated prepubertal gynaecomastia.
    Kağızmanlı GA; Besci Ö; Acinikli KY; Şeker G; Yaşar E; Öztürk Y; Demir K; Böber E; Abacı A
    J Pediatr Endocrinol Metab; 2022 Dec; 35(12):1565-1570. PubMed ID: 36181314
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subcutaneous Testosterone Anastrozole Therapy in Men: Rationale, Dosing, and Levels on Therapy.
    Glaser RL; York AE
    Int J Pharm Compd; 2019; 23(4):325-339. PubMed ID: 31315085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aromatase excess syndrome: a rare autosomal dominant disorder leading to pre- or peri-pubertal onset gynecomastia.
    Fukami M; Miyado M; Nagasaki K; Shozu M; Ogata T
    Pediatr Endocrinol Rev; 2014 Mar; 11(3):298-305. PubMed ID: 24716396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.